EUVIMEDEUVIMED entdecken
Crossref

PPAR-gamma agonist pioglitazone improves endometrial receptivity, reverses endometrial barrier disruption and promotes ovarian function in thin endometrium rats via modulation PPAR-γ/Wnt5/β-catenin pathway

Heqiao Li, Yu Guan, Xinru Chen, Wenfan Tian, Jinghong Xie, Bin Yang

Journal of Reproductive Immunology · 2025-06 · 169 · 104526

DOI: 10.1016/j.jri.2025.104526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2025-06. Verfasst von Heqiao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Hauptthemen laut MEDLINE: PPAR-gamma Agonists, Pioglitazone, Endometrium, Ovary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: China Academy of Chinese Medical Sciences, Beijing Municipal Science and Technology Commission, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thin endometrium (TE) is a common reproductive endocrine disorder, PPAR-γ has been reported to regulate cell proliferation and crosstalk with the Wnt5/β-catenin pathway. However, whether PPAR-γ promotes endometrial epithelial cell proliferation and acts through the Wnt5/β-catenin pathway has not been explored. A rat model of endometrial thinning was established and administered for 15 days, and the morphology of the uterus and ovaries was observed by HE staining. Serum sex hormone levels were measured by enzyme-linked immunosorbent assay (ELISA). The morphology of endometrial surface was observed by electron microscopy. Immunohistochemistry was used to detect the expression of endometrial receptivity, endometrial barrier and ovarian function proteins. Activation of PPAR-γ/Wnt5/β-catenin pathway was analyzed by molecular docking and Western blotting. The results showed that PIO improved endometrial morphology, endometrial thickness, gland number and expression of endometrial tolerance-related proteins, and promoted the repair of endometrial barrier in TE rats. Serum hormone levels, mature follicle and corpus luteum numbers were increased, indicating improved ovarian function. PIO downregulated the Wnt5/β-catenin signaling pathway and increased the expression of ovarian endocrine-related proteins, as shown by western blot analysis. Our findings revealed that thr PPAR-γ agonist pioglitazone inhibited the Wnt5/β-catenin pathway by up-regulating the expression of PPAR-γ and promoted the proliferation of epithelial cells and the repair of the endometrial barrier, which played a role in protecting ovarian function while treating TE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR-gamma AgonistsPioglitazoneEndometriumOvarySignal Transductionbeta CateninWnt Signaling PathwayWnt-5a ProteinGonadal Steroid HormonesFemaleAnimalsRatsRats, Sprague-DawleyUterine DiseasesModels, AnimalEnzyme-Linked Immunosorbent AssayEndometrial Hyperplasia

Stichwörter der Autor:innen

Endometrial barrierEndometrial receptivityOvarian functionPioglitazoneThin endometrium

Substanzen

PPAR-gamma AgonistsPioglitazonebeta CateninWnt-5a ProteinGonadal Steroid Hormones

Autor:innen und Institutionen

  • Department of Gynecology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
  • Department of Gynecology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: jinghongxie2012@163.com.
  • Department of Pathology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: bean5@126.com.

Förderung

  • China Academy of Chinese Medical Sciences
  • Beijing Municipal Science and Technology Commission
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Li, H., Guan, Y., Chen, X., Tian, W., Xie, J., & Yang, B. (2025). PPAR-gamma agonist pioglitazone improves endometrial receptivity, reverses endometrial barrier disruption and promotes ovarian function in thin endometrium rats via modulation PPAR-γ/Wnt5/β-catenin pathway. Journal of Reproductive Immunology, 169, 104526. https://doi.org/10.1016/j.jri.2025.104526

Vancouver

Li H, Guan Y, Chen X, Tian W, Xie J, Yang B. PPAR-gamma agonist pioglitazone improves endometrial receptivity, reverses endometrial barrier disruption and promotes ovarian function in thin endometrium rats via modulation PPAR-γ/Wnt5/β-catenin pathway. Journal of Reproductive Immunology. 2025;169:104526. doi:10.1016/j.jri.2025.104526

BibTeX
@article{Li2025,
  author = {Li, Heqiao and Guan, Yu and Chen, Xinru and Tian, Wenfan and Xie, Jinghong and Yang, Bin},
  title = {PPAR-gamma agonist pioglitazone improves endometrial receptivity, reverses endometrial barrier disruption and promotes ovarian function in thin endometrium rats via modulation PPAR-γ/Wnt5/β-catenin pathway},
  journal = {Journal of Reproductive Immunology},
  year = {2025},
  volume = {169},
  pages = {104526},
  doi = {10.1016/j.jri.2025.104526}
}
Kostenlos starten →